Panther Life Sciences names Mounir Hanana CEO as SmartPatch commercialization begins

Panther Life Sciences has appointed Marcus “Mounir” Hanana as chief executive officer as the company prepares to commercialize its SmartPatch platform in 2027. The move is meant to strengthen Panther’s go-to-market, manufacturing and scaling capabilities across cosmetics, medical aesthetics, dermatology and other therapeutic uses.

Why it matters: - Panther Life Sciences is moving from platform development into commercialization. - The company is targeting cosmetics, medical aesthetics, dermatology and broader therapeutic applications. - The CEO hire brings in leadership experience tied to large-scale manufacturing, global technology and commercial operations.

What happened: - Panther Life Sciences appointed Marcus “Mounir” Hanana as chief executive officer. - Founder Carlos Bhola will remain Executive Chairman and work closely with Hanana. - Panther said Hanana will lead commercialization as the company begins bringing SmartPatch™ to market. - Bhola said the company is ready to deploy SmartPatch in 2027 and needed stronger go-to-market and commercialization capabilities.

The details: - Hanana has 25 years of global leadership experience at Procter & Gamble and Amazon. - His career has included roles spanning businesses from several hundred million dollars in revenue to multibillion-dollar global operations. - At Procter & Gamble, Hanana helped move consumer products from development to market through manufacturing, supply chain and commercial organizations. - At Amazon, Hanana led global technology businesses and most recently served as CFO of Amazon Business. - Panther said those backgrounds match the capabilities needed for its next phase of growth. - Bhola will focus on strategy, product vision and corporate development. - Hanana will oversee operations, commercialization and organizational growth. - Panther’s website is More information. - Panther says its intradermal SmartPatch™ delivers treatments through the skin and is designed as a delivery platform for health, wellness and therapeutics. - The company says its AI-based platform is intended to accelerate product development and personalize treatment and care.

Between the lines: - The hire signals Panther is prioritizing execution over pure invention. - Bringing in an operator with consumer products and enterprise technology experience suggests the company is preparing for manufacturing scale and broader market entry. - The split between Bhola and Hanana separates strategy and product vision from commercial and operational execution.

What's next: - Panther is working toward a 2027 SmartPatch deployment. - The company is expected to keep building commercial infrastructure for consumer and medical uses. - Hanana’s first test will be turning a platform story into a scalable business.

The bottom line: - Panther is betting that a seasoned operator can help turn SmartPatch from a development-stage platform into a commercial health and beauty business.